Scivision BiotechTPE:1786 -0.56%80 Net Margin % is 25.13% as of Dec. 2025, which is 0% below its 10-year median of 25.19. GuruFocus rates TPE:1786 with a GF Score™ of 80/100 and a GF Value™ of NT$115.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Scivision Biotech ranks better than 87.35% on this metric.
The historical rank and industry rank for Scivision Biotech's Net Margin % or its related term are showing as below:
TPE:1786'
s Net Margin % Range Over the Past 10 Years
Min: -11.5 Med: 25.19 Max: 27.57
Current: 18.31
TPE:1786's Net Margin % is ranked better than 87.35% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: 2.08
vs TPE:1786: 18.31
Scivision Biotech (TPE:1786) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Scivision Biotech Net Margin % Related Terms
Scivision Biotech Net Margin % Historical Data
* Premium members only.
The historical data trend for Scivision Biotech's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1786 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Scivision Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scivision Biotech Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Scivision Biotech's Net Margin % distribution charts can be found below:
* The bar in red indicates where Scivision Biotech's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scivision Biotech (TPE:1786) has a Net Margin % of 25.13% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Scivision Biotech and its competitors. This is near median its historical median of 25.19. According to the industry distribution chart, Scivision Biotech ranks #103 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 12.7%.
Is Scivision Biotech's Net Margin % too high?
Scivision Biotech's current Net Margin % of 25.13% is near median its 10-year median of 25.19. The Medical Devices & Instruments industry median Net Margin % is 2.08. Scivision Biotech's value of 25.13% is 1108.2% above this industry median. Based on the distribution chart, Scivision Biotech ranks #103 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Scivision Biotech has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scivision Biotech's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Scivision Biotech ranks #103 out of 814 companies for Net Margin %. This places Scivision Biotech in the top 13% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.08. Scivision Biotech's value of 25.13% is 1108.2% above this benchmark. While the company's 10-year median is 25.19 vs. the industry median of 2.08, Scivision Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.08, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scivision Biotech's current Net Margin % of 25.13% is 1108.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Scivision Biotech and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scivision Biotech's current Net Margin % is 25.13%, which is near median its own 10-year median of 25.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scivision Biotech stock overvalued right now?
Based on GuruFocus' analysis, Scivision Biotech (TPE:1786) is currently considered Possible Value Trap. The stock's GF Value™ is NT$115.23, compared to a current price of NT$53.50 — trading 53.6% below its estimated fair value. The current Net Margin % is 25.13%, which is near median its 10-year median of 25.19 and 1108.2% above the Medical Devices & Instruments industry median of 2.08. Scivision Biotech's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Scivision Biotech (TPE:1786), the current Net Margin % is 25.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scivision Biotech (TPE:1786) Overvalued in 2026?
Based on GuruFocus' analysis, Scivision Biotech stock appears to be undervalued.
The current stock price of NT$53.50 is trading 53.6% below its estimated GF Value™ of NT$115.23.
GuruFocus considers Scivision Biotech to be Possible Value Trap.
Key valuation signals for TPE:1786:
Net Margin %: 25.13% (near median its 10-year median of 25.19)
GF Value™: NT$115.23 vs. price of NT$53.50 (53.6% below fair value)
Industry Position: 1108.2% above the Medical Devices & Instruments median (#103 of 814)
No single metric tells the full story. See the TPE:1786 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.
80GF Score
Get the complete analysis for TPE:1786
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1786 has been successfully added to your 
